UK markets closed

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.7200+0.3200 (+9.41%)
As of 02:57PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.4000
Open3.4500
Bid3.6800 x 3000
Ask3.6900 x 1300
Day's range3.3550 - 3.7200
52-week range2.4900 - 10.3300
Volume1,709,479
Avg. volume2,610,211
Market cap470.379M
Beta (5Y monthly)0.70
PE ratio (TTM)N/A
EPS (TTM)-0.6410
Earnings date03 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date09 Nov 2012
1y target est11.40
  • Motley Fool

    These 3 Former High-Flying Stocks Can Soar Up to 439%, According to Wall Street

    No matter your level of experience investing money on Wall Street, it's been a rough year. Meanwhile, the technology-driven Nasdaq Composite declined close to 30% from its November all-time high, firmly placing it in a bear market. This is why Wall Street analysts typically have a bullish outlook on many of the companies they cover.

  • Motley Fool

    Can This 1 Thing Hurt Vaxart?

    Vaxart (NASDAQ: VXRT) has been involved in the coronavirus vaccine race since the beginning. All of this means there is one big problem for Vaxart right now. Vaxart's biggest problem is the time it's taking the company to bring its candidate through development to commercialization.

  • Motley Fool

    3 Biotech Stocks That Could Help Make You a Fortune

    Biotech stocks have put plenty of investors on the road to riches in recent years. Or we can refer to a smaller player like Novavax, which soared 2,700% in one year on optimism about its coronavirus vaccine program. Investors already know Moderna (NASDAQ: MRNA) for its blockbuster coronavirus vaccine, and that's why it might be overlooked right now.